135 related articles for article (PubMed ID: 15923381)
21. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
22. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
23. Separation and reformation of cell surface dopamine receptor oligomers visualized in cells.
O'Dowd BF; Ji X; Alijaniaram M; Nguyen T; George SR
Eur J Pharmacol; 2011 May; 658(2-3):74-83. PubMed ID: 21371461
[TBL] [Abstract][Full Text] [Related]
24. [Effects of activation and blockade of dopamine receptors on extinction of passive avoidance response in mice with depressive-like state].
Dubrovina NI; Zinov'eva DV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2008; 58(5):605-10. PubMed ID: 19004320
[TBL] [Abstract][Full Text] [Related]
25. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
Ruskin DN; Rawji SS; Walters JR
J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
27. [The role of D1 and D2 dopamine receptors of the rat nucleus accumbens in immunostimulation].
Devoĭno LV; Al'perina EL; Gevorgian MM; Cheĭdo MA
Ross Fiziol Zh Im I M Sechenova; 2005 Nov; 91(11):1281-7. PubMed ID: 16408636
[TBL] [Abstract][Full Text] [Related]
28. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.
Rashid AJ; So CH; Kong MM; Furtak T; El-Ghundi M; Cheng R; O'Dowd BF; George SR
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):654-9. PubMed ID: 17194762
[TBL] [Abstract][Full Text] [Related]
29. Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Akai T; Ozawa M; Yamaguchi M; Mizuta E; Kuno S
J Pharmacol Exp Ther; 1995 Apr; 273(1):309-14. PubMed ID: 7714782
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane.
Dziedzicka-Wasylewska M; Faron-Górecka A; Andrecka J; Polit A; Kuśmider M; Wasylewski Z
Biochemistry; 2006 Jul; 45(29):8751-9. PubMed ID: 16846218
[TBL] [Abstract][Full Text] [Related]
31. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
Prus AJ; Schuck CJ; Rusch KR; Carey LM
Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
[TBL] [Abstract][Full Text] [Related]
32. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
33. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
34. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors.
Ibañez-Sandoval O; Hernández A; Florán B; Galarraga E; Tapia D; Valdiosera R; Erlij D; Aceves J; Bargas J
J Neurophysiol; 2006 Mar; 95(3):1800-11. PubMed ID: 16306171
[TBL] [Abstract][Full Text] [Related]
35. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
[TBL] [Abstract][Full Text] [Related]
36. [Functional interplay of dopamine D1 and D2 receptors in the immune response control in different psychoemotional states].
Al'perina EL; Gevorgian MM
Eksp Klin Farmakol; 2010 Jun; 73(6):2-4. PubMed ID: 20726342
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
38. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.
Torvinen M; Kozell LB; Neve KA; Agnati LF; Fuxe K
J Mol Neurosci; 2004; 24(2):173-80. PubMed ID: 15456930
[TBL] [Abstract][Full Text] [Related]
39. A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2-selective agonist.
MacKenzie RG; Steffey ME; Manelli AM; Pollock NJ; Frail DE
FEBS Lett; 1993 May; 323(1-2):59-62. PubMed ID: 8098694
[TBL] [Abstract][Full Text] [Related]
40. D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.
Chun LS; Free RB; Doyle TB; Huang XP; Rankin ML; Sibley DR
Mol Pharmacol; 2013 Aug; 84(2):190-200. PubMed ID: 23680635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
